CTLA4 and melanoma: This study confirmed previously observed data from melanoma biopsies of patients treated with anti-CTLA-4 followed by PD-1 blockade, namely that a more clonal baseline TCR repertoire was predictive of response to PD-1, but not to CTLA-4 blockade [94].